Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

A method of eliciting an immune response in a patient who has cancer, comprising administering to the patient a composition comprising a population of activated T cells that selectively recognize cancer cells that present a peptide consisting of an amino acid sequence selected from SEQ ID NO:

• 1 to SEQ ID NO:
• 5 or SEQ ID NO:
• 7 to SEQ ID NO:
• 10,
• wherein the activated T cells are produced by contacting T cells with the peptide loaded onto a human class I MEW molecule expressed on the surface of an antigen-presenting cell for a period of time sufficient to activate the T cells,
• wherein said cancer is selected from lung cancer, kidney cancer, brain cancer, stomach cancer, colon or rectal cancer, liver cancer, prostate cancer, leukemia, breast cancer, Merkel cell carcinoma (MCC), melanoma, ovarian cancer, esophageal cancer, urinary bladder cancer, endometrial cancer, gall bladder cancer, and bile duct cancer.